Document:

Exhibit

THIS EXHIBIT HAS BEEN REDACTED TO EXCLUDE INFORMATION THAT IS NOT MATERIAL AND THAT WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.  

EXHIBIT 10.1

DATED  July 3, 2019 

(1)TRANSENTERIX, INC.
(2)    GREAT BELIEF INTERNATIONAL LIMITED

	
	
	AUTOLAP SYSTEM SALE AGREEMENT

38392764_1.docx

THIS AGREEMENT is made on July 3, 2019.
BETWEEN:
		
	(1)
	TransEnterix, Inc., a company incorporated in Delaware, USA, with SEC File No. 000-19437 whose principal executive office is at 635 Davis Drive, Suite 300, Morrisville NC USA 27560 ("Seller"); and

		
	(2)
	Great Belief International Limited, a company incorporated in British Virgin Islands under number 2364376 whose registered office is at P. O. Box 957, Offshore Incorporation Centre, Road Town, Tortola, British Virgin Islands. ("Buyer")

(each of the "Seller" and the "Buyer" being a "Party" and together the "Seller" and the "Buyer" are the "Parties").
BACKGROUND:
		
	(A)
	The Seller has developed the Autolap System. 

		
	(B)
	The Seller has agreed to sell and transfer the System to the Buyer, and the Buyer has agreed to purchase the same, subject to the terms and conditions in this Agreement.

IT IS AGREED:
		
	1.
	    DEFINITIONS AND INTERPRETATION

		
	1.1
	In this Agreement, unless the context otherwise requires:

	
		
	"agreed form"
	means a form which has been agreed by the Parties and which has been duly executed or initialled by them or on their behalf for identification purposes with any alterations that may be agreed between the Parties in writing;

	"Ancillary Agreements"
	means the Cross-License Agreement, the IPR Assignments and the Subscription Agreement;

	"Business Day"
	In respect of any action to be taken by the Buyer, means any day on which the companies in PRC are generally open for business in the PRC, including a Saturday or Sunday which the PRC government temporarily declares to be a working day, but excluding a statutory holiday, a Saturday or Sunday other than a Working Rest Day, and a weekday which the  PRC government temporarily declares to be a rest day; in respect of any action to be taken by the Seller, means a day, other than a Saturday, Sunday or public holiday, on which banks are open for non-automated commercial business in the United States and Business Days means more than one of them;

	"CFDA" 
	means the China Food and Drug Administration;

	"Closing 1"
	means the first completion of the sale and purchase of the System in accordance with clause 4;

	"Closing 2" 
	means the second completion of the sale and purchase of the System in accordance with clause 6;

	"Consideration"
	means the sum specified in clause 3.1;

	" Cross-License Agreement"
	means an agreement between Buyer and Seller, to be entered into at Closing 2 in the form indicated in Schedule 5, wherein: (a)_Seller grants to Buyer the right to use the Platform Software and the Licensed Patents, in each case solely for manufacture, use or sale of the System; (b) Buyer grants back to Seller the right to use the System IPR and any Intellectual Property Rights in improvements to the System IPR or to the System;

	"Encumbrance"
	means any mortgage, charge, pledge, lien or other security interest of any kind, and any right of set off, assignment by way of security, trust or other agreement or arrangement whatsoever for the purpose of providing security or having similar effect to the provision of security and Encumbrances means more than one of them;

1
38392764_1.docx

	
		
	"Intellectual Property Rights"
	means copyright, rights in inventions, patents, know-how, trade secrets, trademarks and trade names, service marks, design rights, rights in get-up, database rights and rights in data, semiconductor chip topography rights, rights in software, rights in domain names and social media accounts, the right to sue for passing off, utility models, and all similar rights  and, in each case:
(a)    whether registered or not;
(b)    including any applications to protect or register such rights;
(c)    including all renewals and extensions of such rights or applications;
(d)    whether vested, contingent or future; and
(e)    wherever existing;

	"IPR Assignments" 
	means the Assignment Agreement for the System IPR in the form provided at Schedule 6, and any other assignments as may be signed by the parties to effect the transfer of the System IPR to the Buyer;

	“Licensed Patents”
	Means the patents indicated  in Schedule 2, Part 2,  as well as any divisionals, continuations, etc. of those patents

	"Nominated Account"
	means the Seller's account as set forth in Error! Reference source not found. to this Agreement;

	"OEM Manufacturers"
	means Novatec Ltd. and Medimor Ltd., companies based in Israel that prior to the date of this Agreement manufactured the AutoLap System under contract with and on behalf of the Seller;

	"Platform Software"
	means certain software utilized in the System as of the date of this Agreement and described in Error! Reference source not found., Part 1.

	"Registration Agent"
	means Xizang Haisco Pharmaceutical Group Co. Ltd., the agent engaged by the Seller to undertake medical device registration for the System with the CFDA.

	"Registration Information"
	means all material test or trial results, analysis, protocols, correspondence, filings, drawings or descriptions, specifications, System information and any other work product of any kind produced, prepared or compiled by the Registration Agent in connection with CFDA registration for the System, and necessary or convenient for Buyer to continue to progress the CFDA registration.

	"System"
	means the laparoscope positioning system previously marketed by MST – Medical Surgical Technologies Ltd as the ‘AutoLap’ System.

	"System Assets"
	means the System Capital Goods, the System Information, the System IPR, and the System Software  and System Asset means one of them;

	"System Capital Goods"
	means the System Stock and the System Tooling and Equipment, including those listed in Schedule 1, Part 4;

	"System Information"
	means all drawings, specifications, procedures, manuals, and other information, know-how and techniques in any form which wholly or partially relate to all or any part of the System design, manufacture, installation, operation, calibration and testing, marketing, or maintenance;

	"System IPR"
	means the Intellectual Property Rights in connection with the System  owned by the Seller, and with respect to patents means in particular the patents indicated in Schedule 1, Part 1 as well as any divisionals, continuations, etc. of those patents;

	"System Software"
	means the  computer software incorporated into the System, as further described in Schedule 1, Part 2 (not including the Platform Software, or any third party development tools, such as Microsoft Development Tools);

	"System Stock"
	means stores, raw materials and components purchased for incorporation into the System, spare parts, and work-in-progress, together with finished products of the System or parts thereof;

2
38392764_1.docx

	
		
	"System Tooling and Equipment"
	means all equipment, machinery, special tooling, moulds, jigs, fittings, and other assets owned by the Seller and used exclusively in the manufacture of the System at the date of this Agreement;

	“Subscription Agreement”
	means that certain Subscription Agreement, dated and executed as of the date hereof and attached as an exhibit hereto pursuant to which Buyer shall purchase 15,000,000 shares of Seller’s common stock at $2.00 per share.

	"Warranties"
	means the representations and warranties set out in Schedule 1 and Warranty means one of them.

		
	1.2
	Unless the context otherwise requires:

		
	1.2.1
	each gender includes the other genders;

		
	1.2.2
	the singular includes the plural and vice versa;

		
	1.2.3
	references to clauses, Schedules or Appendices are to clauses, Schedules and Appendices (if any) of this Agreement;

		
	1.2.4
	references to this Agreement include its Schedule and Appendices (if any);

		
	1.2.5
	references to persons include individuals, unincorporated bodies, government entities, companies and corporations;

		
	1.2.6
	the words 'including' or 'includes' mean including or includes without limitation;

		
	1.2.7
	clause headings do not affect their interpretation; and

		
	1.2.8
	references to legislation include any modification or re-enactment thereof before the date of this Agreement.

		
	2.
	SALE AND PURCHASE OF THE SYSTEM AND THE SYSTEM ASSETS

		
	2.1
	Subject to the terms and conditions of this Agreement the Seller will sell, free from all Encumbrances, and the Buyer will buy, the System and System Assets. 

		
	2.2
	In addition, on the date hereof, the parties are entering into the Cross-License Agreement under which:

		
	2.2.1
	Seller will license Buyer to use the Platform Software and the Licensed Patents, in each case solely for manufacture, use or sale of the System; and

		
	2.2.2
	Buyer will grant back to Seller a license to use the System IPR and any Intellectual Property Rights in improvements to the System IPR or to the System . 

		
	3.
	CONSIDERATION

		
	3.1
	The total consideration for the transfer by Seller to Buyer of the System and the System Assets shall be US$47,000,000.  

		
	3.2
	The consideration shall be paid as follows: 

		
	3.2.1
	US$5,000,000 at Closing 1;

		
	3.2.2
	The purchase of 15,000,000 shares of Seller’s common stock pursuant to the Subscription Agreement to be purchased no later than September 30, 2019; and

		
	3.2.3
	US$12,000,000 at Closing 2.

3
38392764_1.docx

		
	3.3
	All sums payable under this Agreement and the Subscription Agreement are exclusive of VAT (or similar tax) and shall be paid free and clear of all deductions and withholdings whatsoever, unless the deduction or withholding is required by law. If any deduction or withholding is required by law the Buyer shall pay to the Seller such sum as will, after the deduction or withholding has been made, leave the Seller with the same amount as it would have been entitled to receive in the absence of any such requirement to make a deduction or withholding. For the avoidance of doubt, Seller shall be solely responsible for, and Buyer's obligation in the previous sentence shall not apply to, any fees charged by Seller's own bank, and any taxes, levies or assessments required by the government in the Seller's location.  

		
	4.
	CLOSING  1

		
	4.1
	Closing 1 shall take place on July 31 2019.

		
	4.2
	At Closing 1, the matters set out in clauses 4.2.1 and 4.2.2 shall be transacted.

		
	4.2.1
	The Seller shall deliver, procure the delivery of, make available or procure the availability to the Buyer of:

		
	(a)
	this Agreement and the Subscription Agreement, each duly executed by the Seller as of July 3, 2019;

		
	(b)
	a certified copy of the resolutions of the Seller's board of directors approving the transaction and authorising the execution and delivery of this Agreement, the Subscription Agreement and other documents required to be signed by the Seller in accordance with this Agreement; and

		
	(c)
	delivery of the form of instruction letter to be delivered by the Seller to the Seller’s transfer agent regarding the issuance of 15,000,000 shares of Seller’s common stock, issued in the name of the Buyer, in exchange for the funds paid under clause 4.2.2(c).

		
	4.2.2
	The Buyer will:

		
	(a)
	deliver, procure the delivery of, make available or procure the availability to the Seller of:    

		
	(i)
	this Agreement and the Subscription Agreement, each duly executed by the Buyer as of July 3, 2019;

		
	(ii)
	a certified copy of the board resolutions of the Buyer authorising the execution and delivery of this Agreement, the Subscription Agreement and the other documents required to be signed by the Buyer in accordance with this Agreement; 

		
	(b)
	pay the sum of US$5,000,000 to the Seller by way of electronic transfer of funds into the Nominated Account, receipt of which sum in such account by such date shall constitute a good discharge to the Buyer in respect of its obligation under clause 3.2.1.  

		
	(c)
	By no later than September 30, 2019, the Buyer shall pay the sum of US$30,000,000 to the Seller by way of electronic transfer of funds into the Nominated Account, receipt of which sum in such account by such date shall constitute a good discharge to the Buyer in respect of its obligation under clause 3.2.2 and under the Subscription Agreement.  

		
	4.3
	If either Party fails or is unable to perform any obligation required to be performed by it under clause 4.2 at Closing 1 or within the time periods set forth in clause 4.2, the other Party shall not be obliged to complete its obligations under clause 4.2, the sale and purchase of the System, 

4
38392764_1.docx

or any other terms of this Agreement, and may unilaterally terminate this Agreement and/or the Subscription Agreement.
		
	4.4
	If this Agreement terminates pursuant to clause 4.3, each Party’s further rights and obligations cease immediately on termination, save that clauses 1 (Definitions and interpretation), 10.6 (Entire agreement), 10.10 (Costs), 11 (Notices), 12 (Confidential information) and 13 (Governing law and jurisdiction) shall remain in full force and effect and termination shall not affect any Party’s accrued rights and obligations at the date of termination.  

		
	5.
	DELIVERY OF SYSTEM CAPITAL GOODS 

		
	5.1
	The Seller shall, within ten (10) days after Closing 1, deliver the System Capital Goods to Buyer's designated carrier. The System Capital Goods will be delivered on an Ex Works (Incoterms 2010) basis to Buyer's designated carrier at Seller's chosen premises in the United States. Buyer will be responsible, on a timely basis, for taking delivery of the System Capital Goods, and for arranging and paying all costs in relation to shipping, insurance, export and import clearance, and customs duties.  

		
	5.2
	The Buyer or its affiliate shall maintain shipping insurance on the System Capital Goods through  arrival at their final destination, in a minimum amount of US$5,000,000, and the Seller shall be named as the beneficiary on the policy of insurance.  Buyer shall provide proof of such insurance prior to taking delivery of the System Capital Goods in accordance with clause 5.1.  

		
	5.3
	Risk of loss in the System Capital Goods will pass upon delivery to Buyer's designated carrier at Seller's premises, and title will pass on the Seller's receipt of full payment as provided for in clause 6.2.2. 

		
	5.4
	The failure of Buyer (or its affiliate) to take delivery of the System Capital Goods within forty-five (45) days after Buyer makes the goods available in accordance with clause 5.1, shall constitute a material breach of this Agreement.   

		
	5.5
	Buyer shall keep Seller informed of progress in the transportation of the System Capital Goods.  

		
	5.6
	In any case that the Seller fails to deliver the System Capital Goods to Buyer’s affiliate’s in accordance with clause 5.1, the Seller shall refund US$5,000,000 to Buyer without any deductions or withholdings whatsoever, after which this Agreement and its Ancillary Agreements shall automatically terminate.   

		
	6.
	CLOSING 2 

		
	6.1
	Closing 2 shall take place on or before 30 November 2019 at a date, time and place to be agreed by the Parties. 

		
	6.2
	At Closing 2, the matters set out in clauses 6.2.1 through 6.2.3 shall be transacted.

		
	6.2.1
	The Seller shall procure the delivery of, make available or procure the availability to the Buyer of:

		
	(a)
	possession of digital copies of current versions of all of the following: 

		
	(i)
	the System Information;

		
	(ii)
	the Registration Information (to the extent available); 

		
	(iii)
	the System Software (source code and compiled versions);

		
	(iv)
	the Platform Software (compiled versions only)

		
	6.2.2
	The Buyer will pay the sum of US12,000,000 to the Seller by way of electronic transfer of funds for the same day value into the Nominated Account, receipt of which sum in 

5
38392764_1.docx

such account shall constitute a good discharge to the Buyer in respect of its obligation under clause 3.2.3;
		
	6.2.3
	The Seller, or a subsidiary of the Seller, and Buyer shall execute, or cause to be executed, and enter into:

		
	(a)
	the Cross-License Agreement;

		
	(b)
	in respect of the System IPR, the duly executed IPR Assignment  in the agreed forms;

		
	6.3
	If either Party fails or is unable to perform any of its obligation required to be performed by it under clause 6.2 at Closing 2, the other Party shall not be obliged to complete its obligations under clause 6.2, the sale and purchase of the System, or any other terms of this Agreement, and may unilaterally terminate this Agreement, in which case: 

		
	6.3.1
	All of the executed Ancillary Agreements (other than the Subscription Agreement) will automatically terminate; 

		
	6.3.2
	If termination of this Agreement is caused by the Buyer’s failure to perform any of its obligation required to be performed by it under clause 6.2 at Closing 2, Buyer shall promptly return or procure the return of all of the System Capital Goods to Seller's designated premises in the United States, at Buyer's own risk and expense; and

		
	6.3.3
	If termination of this Agreement is caused by the Seller’s failure to perform any of its obligation required to be performed by it under clause 6.2 at Closing 2, Buyer shall promptly return or procure the return of all of the System Capital Goods to Seller's designated premises in the United States, at Seller's own risk and expense; 

		
	6.3.4
	Upon return of the System Capital Goods in accordance with clause 6.3.2 or 6.3.3, Seller shall return all funds received by it from Buyer under clause 4.2.2(b) and 6.2.2 prior to that date; provided, however, that if the failure of Closing 2 is a result of Buyer's failure to perform any of its other obligations hereunder, the Seller will be entitled (without limitation to its rights to claim any damages or other compensation to which it may be entitled) to retain US$[XXXXXXXXX] as damages; and if the failure of Closing 2 is a result of Seller's failure to perform any of its other obligations hereunder, the Buyer will be entitled to claim damages and compensation including but not limited to its expenses for shipping the System Capital Goods from the US to Hong Kong. For the avoidance of doubt, Buyer shall not be obligated or entitled to return the shares of Seller’s common stock purchased at Closing 1 in accordance with clauses 3.2.2 and 4.2, nor shall Seller by obligated to repay the sums paid for such shares under the Subscription Agreement. 

		
	6.4
	If this Agreement terminates pursuant to clause 6.3, each Party’s further rights and obligations cease immediately on termination, save that clauses 1 (Definitions and interpretation), 6.3 (consequences of termination), 10.6 (Entire agreement), 10.10 (Costs), 11 (Notices), 12 (Confidential information) and 13 (Governing law and jurisdiction) shall remain in full force and effect, and termination shall not affect any Party’s accrued rights and obligations at the date of termination.

		
	7.
	ACTIONS AFTER CLOSING 2

After the conclusion of Closing 2, the Parties will have the following rights and obligations. 
		
	7.1
	Further acts - transfer of Registration Information

		
	7.1.1
	It is anticipated that Buyer will not use the services of the Registration Agent, but will use its own designated agent for the CFDA registration.

6
38392764_1.docx

		
	7.1.2
	The Parties will procure the Registration Agent's cooperation with the transfer of the Registration Information to Buyer or its designee. 

		
	7.1.3
	For a period of up to six months after Closing 2, Seller shall provide, or ensure that the Registered Agent provides, support to Buyer to ensure that the Registration Information is complete, and to respond to any reasonable queries that Buyer may have with respect to the Registration Information or the steps undertaken prior to Closing 1 in preparation for CFDA registration.

		
	7.1.4
	Seller shall bear any fees and expenses of the Registration Agent in regard to the undertakings under 7.1.2 to 3.

		
	7.2
	Transfers of registered System IPR 

Seller shall cooperate with Buyer to do or procure to be done all acts and things reasonably required to record the transfer of the registered System IPR (being all patents, and trademarks within the System IPR) to the Buyer through official filings with the relevant registration authorities. Seller will provide proof of its commercially reasonable efforts to complete these filings within 10 Business Days after Closing 2. 
		
	7.3
	Knowledge transfer and support

		
	7.3.1
	Seller shall provide all necessary resources and support  to ensure a full and complete transfer of the System IPR, and further to 7.3.2 will use its commercially reasonable efforts to make Buyer / OEM Manufacturer personnel working with the System understand the technology and methods embodied in the System and necessary for its manufacture and servicing.  

		
	7.3.2
	At no cost to Buyer, Seller shall provide reasonable support in the first six months after Closing 2 to Buyer. For the avoidance of any doubt, when support is demanded by the Buyer, Seller shall provide personnel that are qualified to support. Support shall be provided on a timely basis when requested by the Buyer either remotely (as a preference), at OEM Manufacturer's facility in Israel, or at Seller's facility in the US, as agreed by Buyer and Seller on an on-going basis. Seller and Buyer will each be responsible for its own costs of travel etc. in respect of such support services. If additional support beyond that provided for above is required by Buyer in any period, Buyer may purchase such additional support services from Seller at Seller's then current standard rates for technical services, and subject to reimbursement of Seller's reasonable costs for travel, etc. 

		
	7.3.3
	Seller will introduce Buyer to the OEM Manufacturers with a view to facilitating Buyer's establishment of arrangements with the OEM Manufacturers for production of the System. However, it will be Buyer's sole responsibility to negotiate, enter into and ensure performance of any agreement with the OEM Manufacturers. 

		
	8.
	    WARRANTIES

		
	8.1
	The Seller represents, warrants and undertakes to the Buyer that at Closing 1 and Closing 2 the Warranties set out in Schedule 1, Part A, are true, accurate and not misleading. 

		
	8.2
	The Buyer represents, warrants and undertakes to the Seller that at Closing 1 and Closing 2 the Warranties set out in Schedule 1, Part B, are true, accurate and not misleading.

		
	8.3
	For the purpose of this clause 8 the term fairly and reasonably disclosed means disclosed in such manner and in such detail as to enable a reasonable person to make an informed and accurate assessment of the matter concerned.

		
	8.4
	Each Party acknowledges that the other has entered into this Agreement on the basis of such Warranties. For the avoidance of doubt, claims in relation to breach of the representations and 

7
38392764_1.docx

warranties when made by the Parties may be brought for 24 months after the commencement of sales of the System by Buyer. 
		
	8.5
	Each of the Warranties is a separate warranty and will not be limited or restricted by reference to the terms of any other Warranty or any other term of this Agreement.

		
	8.6
	The System is sold "as is". The Seller makes no warranties or representations other than those in Schedule 2, and excludes to the full extent permitted by law any other warranties whatsoever, including without limitation any warranties as to the suitability of the System for any particular purpose, as to its merchantability or marketability, or as to Buyer's ability to obtain any regulatory approvals in relation to the System. 

		
	9.
	    LIABILITIES AND INDEMNITY

		
	9.1
	Definitions 

In this clause:
	
		
	"Losses" 
	means all damages, liabilities, demands, costs, expenses, claims, actions and proceedings (including all consequential, direct, indirect, special or incidental loss or punitive damages or loss, legal and other professional fees, cost and expenses, fines, penalties, interest and loss of profit or any other form of economic loss (including loss of reputation))

	"Minimum Liability"
	 means US$[XXXXXXX];

	"Claim Period"
	means the period following Closing 2 and continuing until 24 months after the commencement of sales of the System by Buyer.

and a reference to a claim is a reference to a claim by a Party on the grounds indicated in clause 9.2.
		
	9.2
	Indemnity

Each Party will, to the extent that a claim does not arise from the negligence or wilful default of the other Party, on demand indemnify and keep indemnified the other Party from and against all Losses suffered or incurred by the other Party arising out of or in connection with:
		
	9.2.1
	any act or omission by the first Party that is in breach of this Agreement; 

		
	9.2.2
	any breach of the Warranties by the first Party, provided that the claim is issued and served on the other Party during the Claim Period; 

		
	9.2.3
	any third party claim relating to the provision, supply or use of the System, provided that in the case of a third party claim brought against Buyer, the third party claim is served on the Buyer during the Claim Period.

		
	9.3
	De minimis claims

Neither Party shall be liable for a claim if the liability of the other Party for that claim when added to the total liability of the other Party under all previous claims does not exceed in aggregate the Minimum Liability.
		
	9.3.1
	Once the total of the claims exceeds in aggregate the Minimum Liability, the breaching Party shall be liable for the whole amount of such claim and not just for the amount exceeding the Minimum Liability.

		
	9.3.2
	No single claim may be made against a Party under the Warranties if the amount to be claimed does not exceed US$[XXXXXX].

		
	9.4
	Maximum liability

8
38392764_1.docx

The aggregate liability of the Seller or Buyer (as the case may be) in respect of all claims for breach of the Warranties shall not exceed US$[XXXXXXXXX].
		
	9.5
	Pre-Notice of a claim

The claiming Party shall not bring a claim against the other Party unless written notice has been given to the other Party within sixty (60) days after the claiming Party becomes aware of the grounds for a claim, providing details of the nature of the claim in reasonably sufficient detail and, so far as practicable, the amount claimed.
		
	9.6
	Specific Limitations

		
	9.6.1
	Neither Party shall be able to bring a claim against the other if and to the extent that:

		
	(a)
	the breach on which the claim is based occurs as a result of any legislation not in force at the date of this Agreement taking effect retrospectively, any increase in the rates of taxation in force at that date or as a consequence of a change in the interpretation of the law in any jurisdiction after the date of this Agreement,

		
	(b)
	the claim relates to any loss for which the Party is indemnified by insurance.

		
	9.6.2
	If a Party is prevented by clause 9.6.1 from bringing any claim in whole or in part, the losses, costs or damages the Party would have sought to recover in such claim shall not be taken into account when calculating the Minimum Liability.

		
	9.6.3
	No claim shall be made by a Party in relation to a fact, omission, if the Party has actual, constructive or imputed knowledge of the fact, omission, circumstance or occurrence at the time of execution of this Agreement.

		
	9.7
	Conduct of claims

When a Party becomes aware of any third party claim that might give rise to a claim against the other Party out of or in relation to the System or System Assets, having given notice to the other Party in accordance with clause 9.5, the first Party shall:
		
	9.7.1
	not make any admission of liability or agreement or compromise with any party without prior consultation with and the agreement of the other Party;

		
	9.7.2
	take such action to avoid, dispute, resist, appeal, compromise or contest the dispute as the other Party may request, at the other Party's expense; and

		
	9.7.3
	make available to the other Party all information required and available to enable the other Party to avoid, dispute, resist, appeal, compromise or contest the claim and any liability connected with the claim, 

provided that the first Party shall not be obliged to take any action which is likely to materially prejudice the System or the first Party.
		
	9.8
	Recovery from third parties

If a Party receives any payment or benefit from any policy of insurance or any third party other than the other Party as a result of the circumstances giving rise to a claim, and the other Party has made payment to the first Party in respect of that claim, the first Party shall as soon as practicable after receipt, pay to the other Party an amount which is the lesser of the amount of the payment or benefit received from the insurer or other third party and the payment received from the other Party, having deducted all costs, charges and expenses reasonably incurred by the first Party in obtaining the payment or benefit.
		
	9.9
	General

9
38392764_1.docx

		
	9.9.1
	Nothing in this clause shall in any way diminish Parties' obligation to take reasonable measures to  mitigate their losses.

		
	9.9.2
	If any potential claim arises by reason of a liability that is contingent only, then the Seller shall not be under any obligation to make any payment for that claim until such time as the contingent liability becomes actual.

		
	9.9.3
	The Buyer confirms to the Seller that it is not at the date of this Agreement, and after discussion with its accountants and attorneys, aware of any matter or thing that in its reasonable opinion would or may give rise to any claim.

		
	9.9.4
	Nothing contained in this clause or any other terms of this Agreement shall affect any claim or other action by the Buyer in the case of fraud or other dishonesty or any omission or wilful or fraudulent misstatement the Seller or its agents may make or commit.

		
	10.
	    MISCELLANEOUS

		
	10.1
	Variation

Variations to this Agreement will only have effect when agreed in writing and signed by each of the Parties.
		
	10.2
	Severability

If any provision of this Agreement (wholly or partly) is or becomes illegal, invalid or unenforceable, the remaining provisions shall remain in full force and effect. If such provision would be legal, valid and enforceable if part of it were deleted or amended, the provision will apply with the required deletion or amendment provided that neither Party suffers any materially adverse effect.
		
	10.3
	Waiver

Unless otherwise agreed in writing, no failure, delay, indulgence, act or omission by either Party in exercising any right or remedy will be deemed a waiver of that, or any other, right or remedy.
		
	10.4
	Further assurance

Each Party will, at its own cost, do all further acts and execute all further documents necessary to give effect to this Agreement both on and after Closing 1.
		
	10.5
	Assignment

		
	10.5.1
	Except as otherwise agreed by the Parties, neither Party may assign or grant an Encumbrance over or deal in any way with any of its rights under this Agreement; provided, however, that Seller shall have the right to freely transfer all of its rights and obligations under this Agreement to any party acquiring substantially all, or a major part, of the business and/or assets of the Seller, as long as the successor assumes all of Seller’s obligations to Buyer; and Buyer shall have the right to freely transfer all of its rights and obligations under this Agreement to any party acquiring substantially all, or a major part, of the business and/or assets of the Buyer, as long as the successor assumes all of Buyer’s obligations to Seller under this Agreement.

		
	10.6
	Entire agreement

This Agreement and documents referred to in it represent the entire agreement between the Parties and supersede all previous agreements and understanding of the Parties relating to acquisition of the System made available in this Agreement whether written or oral. Further, each Party acknowledges that it does not rely on, and shall have no remedy in respect of any 

10
38392764_1.docx

statement, representation, assurance or warranty (whether of fact or law made innocently or negligently).
		
	10.7
	No joint venture or agency

The Parties are independent contractors, and nothing in this Agreement is intended to create any joint venture or agency relationship between the Parties. No Party may purport to create or assume any obligation on behalf of the other. 
		
	10.8
	Succession

This Agreement will bind and benefit each Party’s respective successors and permitted assignees. Any successor and/or assignee shall in its own right be able to enforce any term of this Agreement in accordance with its terms as if it were in all respects a party to this Agreement, but until such time, any such successor or assignee shall have no rights whether as a third party or otherwise.
		
	10.9
	Counterparts

This Agreement may be signed in any number of separate counterparts. Each, when executed and delivered by a Party, will be an original. All counterparts will together constitute one instrument.
		
	10.10
	Costs

The Parties will each pay their own costs in connection with the negotiation, preparation and implementation of this Agreement and any documents referred to in or incidental to this Agreement.
		
	11.
	    NOTICES

		
	11.1
	Notices under this Agreement will be in writing and sent to the person and address in clause 11.2. They may be given, and will be deemed received:

		
	11.1.1
	by international courier: five Business Days after posting;

		
	11.1.2
	by hand: on delivery.

		
	11.1.3
	by e-mail: on the next Business Day after sending to the correct address (provided that no notice of failure of delivery is received by the sender).

		
	11.2
	Notices will be sent:

		
	11.2.1
	to the Seller at: 

Anthony Fernando
Chief Operating Officer 
TransEnterix, Inc.

with copies to:
Joshua Weingard
Chief Legal Officer

 

and

Kathleen Frost

11
38392764_1.docx

Vice President - Intellectual Property
TransEnterix, Inc.

		
	11.2.2
	to the Buyer at: 

Wang Yan
Authorized Representative
Great Belief International Limited

		
	12.
	    CONFIDENTIAL INFORMATION

		
	12.1
	Neither Party will, without the other’s prior written consent, disclose:

		
	12.1.1
	the existence or terms of this Agreement; provided, however, if this Agreement or certain of its terms are material to Seller, Seller is authorized to disclose the terms of the Agreement in accordance with U.S. securities laws, including filing this Agreement with its filings with the U.S. Securities and Exchange Commission; and

		
	12.1.2
	any information relating to the customers, suppliers, methods, products, plans, finances, trade secrets or otherwise to the business or affairs of the other Party,

together the Confidential Information.
		
	12.2
	Neither Party will use the other's Confidential Information except to perform this Agreement or as contemplated by this Agreement.

		
	12.3
	Disclosure of Confidential Information may be made to such of a Party's officers, employees, professional advisers and consultants as reasonably necessary to advise on this Agreement and the transaction as a whole on the condition that the disclosing Party is responsible for such third party's compliance with the obligations under this clause. Disclosure may also be made as required by law, the Securities and Exchange Commission, any stock exchange, or any other regulatory body. 

		
	12.4
	Confidential Information does not include information which is:

		
	12.4.1
	publicly available, other than as a result of a breach of this Agreement by a Party; or

		
	12.4.2
	lawfully available to a Party from a third party free from any confidentiality restriction; or

		
	12.4.3
	required by law, regulation or by order or ruling of a court or administrative body of a competent jurisdiction to be disclosed (but in which case to the absolute minimum necessary) provided that the disclosing Party shall use its  reasonable endeavours to first consult fully with the other Party to establish whether and, if so, how far it is possible to prevent or restrict such enforced disclosure and take all steps as it may reasonably require to achieve prevention or restriction.

		
	12.5
	Without the express written consent of Seller, Buyer shall not make any public announcement or otherwise disclose to any third party the existence of this Agreement or any agreement ancillary to it, or the fact that discussions concerning a potential collaboration are taking place, except as required by law, the Securities and Exchange Commission, any stock exchange, or any other regulatory body. In the event such a disclosure is required, Buyer shall notify Seller no less than 24 hours in advance of the disclosure. 

		
	12.6
	Without the express written consent of Buyer, Seller shall not make any public announcement or otherwise disclose to any third party the existence of this Agreement or any agreement 

12
38392764_1.docx

ancillary to it, or the fact that discussions concerning a potential collaboration are taking place, except as required by law, the Securities and Exchange Commission, any stock exchange, or any other regulatory body. In the event such a disclosure is required, Buyer shall notify Seller no less than 24 hours in advance of the disclosure. 
		
	13.
	    GOVERNING LAW AND JURISDICTION

		
	13.1
	This Agreement and any dispute or claim arising out of, or in connection with, it, its subject matter or formation (including non-contractual disputes or claims) shall be governed by, and construed in accordance with, the laws of Hong Kong, excluding the United Nations Convention on the International Sale of Goods.

		
	13.2
	Any dispute, difference or claim arising out of, in connection with or relating to this Agreement shall be submitted to and finally resolved by arbitration in Hong Kong under the auspices of the Hong Kong International Arbitration Commission (“HKIAC”), in accordance with the HKIAC Administered Arbitration Rules then in effect, which rules are hereby incorporated by reference into this Agreement. The arbitral tribunal shall consist of three arbitrators. One of the arbitrators shall be a national of the PRC, one a national of the US, and one of a third country. The arbitral proceedings shall be conducted in English.

This document has been executed by the duly authorized representatives of the Parties on the date written at the beginning of it.

	
		
	Executed by TransEnterix Inc. acting by Anthony Fernando, its COO.
	

/s/ Anthony Fernando 

	Executed by Great Belief International Limited acting by Mr. Wang Yan, its authorized representative.
	

/s/ Wang Yan

14.    

13
38392764_1.docx

LIST OF SCHEDULES AND EXHIBITS

		
	Schedule 1
	System Assets

Patents to be Assigned 
    Trademarks and Trademark Registrations 
    System Software 
System Capital Goods and Inventory
		
	Schedule 2
	Platform Software

		
	Schedule 3
	Warranties

		
	Schedule 4
	Nominated Account

		
	Schedule 5
	Cross-License Agreement

		
	Schedule 6
	Assignment Agreement

15.    

1
38392764_1.docx

WARRANTIES
PART A – Seller Warranties
		
	1.
	The Seller

		
	1.1
	The Seller is a company duly incorporated and existing under the laws of Delaware, USA.

		
	1.2
	The Seller has all requisite corporate power and authority to execute and perform this Agreement and all agreements and documents ancillary to it.

		
	1.3
	This Agreement and all agreements and documents ancillary to it constitute valid, legal, binding and enforceable obligations on the Seller.

		
	1.4
	To the Seller's knowledge, no order has been made, petition presented or resolution passed for the winding-up of the Seller and no administration order or administration application or notice of appointment of or notice of intention to appoint an administrator has been made or issued in relation to the Seller.

		
	1.5
	No receiver or administrative receiver has been appointed over any part of the System or the System Assets, no application has been made to the court for any such appointment, and no power of sale or power to appoint a receiver or administrative receiver under the terms of any charge, mortgage or security over the System Assets has become exercisable.

		
	1.6
	Performance by the Seller of the terms of this Agreement and such agreements and documents ancillary to it do not and will not conflict with or result in a breach of any of the provisions of the Seller memorandum or articles of association or any contractual, governmental or public agreement or other obligation made or given by the Seller, or any applicable laws, regulations, acts and other governmental policies especially those of the United States of America.

		
	2.
	The System Assets

		
	2.1
	The Seller or its indirect wholly owned subsidiary TransEnterix Europe, S.A.R.L., acting through its Swiss branch being established under the name “TransEnterix Europe SARL, Bertrange, Swiss Branch Lugano (the “Subsidiary”) has good title to all the System Assets and is the legal and beneficial owner of all the System Assets.  No System Asset are subject to any Encumbrance as of the date of transfer to Buyer.

		
	2.2
	To the Seller’s best knowledge, it is not aware of other parties’ rights which would be infringed upon by the use of the System Assets by the Buyer subject to this Agreement.  

		
	2.3
	The System Assets provided to Buyer are inclusive of all the versions of the System Assets (including the historical and latest versions, especially for the System Information, System IPR and System Software) created, possessed and obtained by the Seller.

		
	3.
	Intellectual Property Rights

		
	3.1
	The Subsidiary is the legal owner of the System IPRs.

		
	3.2
	To the Seller's and Subsidiary’s knowledge, none of the System IPRs are subject to any dispute, infringement and/or challenge.

		
	3.3
	All System IPRs are freely assignable without requiring any consent.

		
	3.4
	To the Seller's knowledge, none of the elements or activities of the System have infringed the Intellectual Property Rights of any person in circumstances which would entitle any person to make a claim against the Seller. The Seller has not received notice of any claim which alleges that the Seller is infringing such person's Intellectual Property Rights in relation to the System.

1
38392764_1.docx

		
	3.5
	The System IPRs are not subject to any Encumbrance or any other rights exercisable by other parties, and the Seller is not obliged to grant any Encumbrance in respect of the System IPRs.

		
	4.
	Information Technology

		
	4.1
	If the Subsidiary is the legal and beneficial owner of the System Software, then the Subsidiary is the one and only legal and beneficial owner of such System Software; if the Subsidiary is not the legal and beneficial owner of any portion of the System Software or Platform Software, then the Subsidiary and its affiliates, including the Seller, have the contractual right to use, the System Software or Platform Software, free from Encumbrances and all other rights exercisable by other parties. The Seller has obtained all necessary rights from third parties to permit the Subsidiary and its affiliates, including the Seller to use the System Software and Platform Software exclusively and without restrictions and is able to cause the Subsidiary to transfer the System Software and Platform Software to the Buyer.

		
	4.2
	The Subsidiary  licenses all software necessary to enable the System to continue in the ordinary course of business and the Seller is able to cause the Subsidiary to transfer such software to the Buyer.

		
	4.3
	The Seller is not aware of any fact, matter, event or circumstance which may adversely affect the continued use of the System Software or Platform Software by Buyer after Closing 2.

		
	5.
	Litigation

		
	5.1
	Neither the Seller nor any person for whom the Seller may be vicariously liable in relation to the System or the System Assets is engaged, concerned or involved in (whether as an applicant, respondent or otherwise) any litigation, arbitration or other proceedings relating to the System or the System Assets which are in progress, threatened or pending by or against the Seller or the System or any of the System Assets and there are no facts of circumstances known to the Seller likely to give rise to any such litigation, arbitration or other proceedings.

PART A – Buyer Warranties
		
	1.1
	The Buyer is a company duly incorporated and existing under the laws of British Virgin Islands.

		
	1.2
	The Buyer has all requisite corporate power and authority to enter into and perform this Agreement and all agreements and documents ancillary to it.

		
	1.3
	This Agreement and all agreements and documents ancillary to it constitute valid, legal, binding and enforceable obligations on the Seller.

		
	1.4
	To the knowledge of the Buyer, no order has been made, petition presented or resolution passed for the winding-up of the Buyer and no administration order or administration application or notice of appointment of or notice of intention to appoint an administrator has been made or issued in relation to the Buyer.

		
	1.5
	No receiver or administrative receiver has been appointed over any part of the business or assets of Buyer, no application has been made to the court for any such appointment, and no power of sale or power to appoint a receiver or administrative receiver under the terms of any charge, mortgage or security over the System Assets has become exercisable.

		
	1.6
	Performance by the Buyer of the terms of this Agreement and such agreements and documents ancillary to it do not and will not conflict with or result in a breach of any of the provisions of the Buyer memorandum or articles of association or any contractual, governmental or public agreement or other obligation made or given by the Buyer.

2
38392764_1.docxExhibit

Exhibit 10.2
CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT
THIS CONSENT AND SECOND AMENDMENT TO LOAN AND SECURITY AGREEMENT (this “Amendment”), dated as of July 10, 2019 (the “Amendment Effective Date”), is made by and among TRANSENTERIX, INC., a Delaware corporation (“Parent”), TRANSENTERIX SURGICAL, INC., a Delaware corporation (“TSI”), TRANSENTERIX INTERNATIONAL, INC., a Delaware corporation (“TII”), and SAFESTITCH LLC, a Virginia limited liability company (“SafeStitch” and together with Parent, TSI and TII, individually and collectively, jointly and severally, “Borrowers” or “Borrower”), the several banks and other financial institutions or entities party to the Loan Agreement (collectively referred to as “Lender”), and HERCULES CAPITAL, INC., a Maryland corporation, as administrative agent and collateral agent for itself and Lender (“Agent”).
RECITALS
A.    Borrowers, Lender and Agent are parties to a Loan and Security Agreement dated as of May 23, 2018, as amended by the First Amendment to Loan and Security Agreement dated May 7, 2019 (as further amended, restated, supplemented or otherwise modified from time to time, the “Loan Agreement”).
B.    Borrowers have requested that Agent and Lender consent to Parent entering into a certain Autolap System Sale Agreement by and between Parent and Great Belief International Limited, a British Virgin Islands company (“GBI”) in substantially the form attached hereto as Exhibit A (the “Purchase Agreement”) pursuant to which, among other things, (i) Parent will sell, and GBI will purchase, the System and System Assets (as each term is defined in the Purchase Agreement, collectively, the “Specified Assets”), and (ii) Parent and GBI will enter into the Cross-License Agreement (as defined in the Purchase Agreement) (collectively, the “Autolap Transaction”), and Agent and Lender are willing to consent to the consummation of the Autolap Transaction on the terms and conditions set forth below.
C.    Borrowers, Lender and Agent have agreed to certain amendments to the Loan Agreement, subject to the terms and conditions set forth below.
AGREEMENT
NOW, THEREFORE, for valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:
SECTION 1.DEFINED TERMS.  Capitalized terms used but not defined in this Amendment (including in the Recitals) shall have the meanings assigned to such terms in the Loan Agreement.
SECTION 2.    CONSENT TO AUTOLAP TRANSACTION.
(A)    Notwithstanding the restrictions set forth in the Loan Agreement, including without limitation, the restrictions set forth in Section 7.8 (Transfers) of the Loan Agreement, Agent and Lender hereby consent to the consummation of the Autolap Transaction and the other transactions contemplated in the Purchase Agreement, subject to the terms of this Amendment and compliance by Borrowers with all of the conditions and requirements set forth herein.  The consent provided in this Section 2 shall be deemed revoked if Borrowers are in breach of any provision of this Amendment.  Effective upon the consummation of the Autolap Transaction, all security interests and liens of Agent granted by Parent in the Specified Assets shall automatically be released and terminated.  In furtherance of the foregoing (i) Agent authorizes Parent, GBI or their respective designees to file a UCC-3 termination statement in the form attached hereto as Exhibit B and (ii) Agent will promptly take all other reasonable actions, including delivering any intellectual property releases, as may be reasonably requested by Borrowers, at Borrowers’ expense, in connection with Agent’s above-described release and termination of all security interest and liens granted to Agent by Parent in the Specified Assets.
(B)    The consent provided in this Section 2 shall be limited precisely as written and shall not be deemed to (i) be a waiver or modification of any other term or condition of any Loan Document, or (ii) prejudice any right or remedy which Agent or Lender may now have or may have in the future under or in connection with any Loan Document.
SECTION 3.    AMENDMENTS TO THE LOAN AGREEMENT.  Subject to all of the terms and conditions set forth in this Amendment, Borrowers, Agent and Lender hereby agree to the following amendments to the Loan Agreement effective as of the Amendment Effective Date.
(A)    Section 7.21(e) of the Loan Agreement is hereby amended and restated in its entirety to read as follows:
“(e)    For purposes of this Section 7.21, “Waiver Condition” means:
(i)    for any period of determination during the 2019 fiscal year, Borrowers shall maintain, at all times, unrestricted Cash in one or more accounts subject to Account Control Agreements in an amount equal to at least $7,000,000; and
(ii)    for any period of determination during each fiscal year following the 2019 fiscal year, commencing with the fiscal year ending December 31, 2020, satisfaction of either of the following conditions at all times during such period of determination:
		
	(A)
	Borrowers shall maintain unrestricted Cash in one or more accounts subject to Account Control Agreements in an amount equal to at least 166% of the principal amount of the Term Loans outstanding; or

		
	(B)
	(x) Borrowers shall maintain unrestricted Cash in one or more accounts subject to Account Control Agreements in an amount equal to at least 110% of the principal amount of the Term Loans outstanding, and (y) Parent’s market capitalization (determined based on Parent’s public closing price per share (as quoted by Bloomberg L.P. or such other inter-dealer quotation system reasonably acceptable to Agent) multiplied by the fully diluted shares outstanding) shall be at least $150,000,000 (calculated based on a 10-trading day volume weighted average price) at all times, provided that if Parent’s market capitalization falls below $150,000,000, the Waiver Condition shall be deemed satisfied upon Borrowers depositing within five Business Days after Parent’s market capitalization falls below $150,000,000 additional unrestricted Cash into one or more accounts subject to Account Control Agreements in an amount to satisfy the conditions set forth in Section 7.21(e)(ii)(A).”

(B)    Exhibit F to the Loan Agreement is hereby amended and restated in its entirety as attached to this Amendment.
SECTION 4.    CONDITIONS TO THIS AMENDMENT.  The effectiveness of Sections 2 and 3 of this Amendment is subject to Borrowers’ satisfaction of each of the following conditions:
(A)    This Amendment.  Agent shall have received this Amendment executed by Agent, Lender and Borrowers.
(B)    Prepayment.  Lender shall have received a principal payment of $15,000,000, which payment shall not be subject to any Prepayment Charge.
(C)    No Default.  No Event of Default shall have occurred and be continuing immediately prior, or after giving effect, to the consummation of the Autolap Transaction.
SECTION 5.    EFFECT ON LOAN DOCUMENTS; RELEASE.
(A)    Except as specifically amended by this Amendment, all Loan Documents shall continue to be in full force and effect and are ratified and confirmed in all respects.  The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of any Lender or Agent under any of the Loan Documents, and it shall not constitute a waiver of any provision of the Loan Documents.  Any reference to the Loan Agreement in any other Loan Document shall be a reference to the Loan Agreement as amended by this Amendment.
(B)    In consideration of the agreements of Agent and each Lender contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each Borrower, on behalf of itself and its successors, assigns, and other legal representatives, hereby fully, absolutely, unconditionally and irrevocably releases, remises and forever discharges Agent and each Lender, and its successors and assigns, and its present and former shareholders, affiliates, subsidiaries, divisions, predecessors, directors, officers, attorneys, employees, agents and other representatives (Agent, Lenders and all such other persons being hereinafter referred to collectively as the “Releasees” and individually as a “Releasee”), of and from all demands, actions, causes of action, suits, covenants, contracts, controversies, agreements, promises, sums of money, accounts, bills, reckonings, damages and any and all other claims, counterclaims, defenses, rights of set-off, demands and liabilities whatsoever of every name and nature, known or unknown, suspected or unsuspected, both at law and in equity, which such Borrower, or any of its successors, assigns, or other legal representatives may now or hereafter own, hold, have or claim to have against the Releasees or any of them for, upon, or by reason of any circumstance, action, cause or thing whatsoever which arises at any time on or prior to the day and date of this Amendment, for or on account of, or in relation to, or in any way in connection with the Loan Agreement, or any of the other Loan Documents or transactions thereunder or related thereto (collectively, the “Released Claims”).  Each Borrower understands, acknowledges and agrees that the release set forth above (the “Release”) may be pleaded as a full and complete defense and may be used as a basis for an injunction against any action, suit or other proceeding which may be instituted, prosecuted or attempted in breach of the provisions of such release.  Each Borrower agrees that no fact, event, circumstance, evidence or transaction which could now be asserted or which may hereafter be discovered shall affect in any manner the final, absolute and unconditional nature of the release set forth above.  Without limiting the generality of the foregoing, each Borrower hereby waives the provisions of any statute or doctrine that prevents a general release from extending to claims unknown by the releasing party, including, without limitation, California Civil Code Section 1542, which provides:
A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.
Each Borrower acknowledges that the agreements in this Section are intended to be in full satisfaction of all or any alleged injuries or damages arising in connection with the Released Claims.  Each Borrower acknowledges that the Release constitutes a material inducement to Agent and Lender to enter into this Amendment and that Agent and Lender would not have done so but for Agent’s and Lender’s expectation that the Release is valid and enforceable in all events.
SECTION 6.    REPRESENTATIONS AND WARRANTIES.  Each Borrower represents and warrants, on behalf of itself and each of the other Loan Parties, to Agent and Lender as follows:
(A)    Such Borrower’s execution, delivery and performance of this Amendment (i) have been duly authorized by all necessary corporate action of such Borrower; (ii) will not result in the creation or imposition of any Lien upon the Collateral (other than Permitted Liens and the Liens created by the Loan Documents, including the Intellectual Property Security Agreement); (iii) do not violate any material provisions of such Borrower’s Certificate of Incorporation, bylaws, certificate of formation or operating agreement, as applicable, or any law, regulation, order, injunction, judgment, decree or writ to which such Borrower is subject; and (iv) except as described on Schedule 5.3 to the Loan Agreement, does not violate any material contract or agreement or require the consent or approval of any other Person which has not already been obtained.
(B)    This Amendment has been duly executed and delivered on such Borrower’s behalf by a duly authorized officer thereof, and constitutes a legal, valid and binding obligation of such Borrower, enforceable in accordance with its terms, subject to bankruptcy, reorganization, insolvency, moratorium and other similar laws affecting the enforcement of creditors’ rights generally and the exercise of judicial discretion in accordance with general principles of equity.
(C)    All of Borrowers’ representations and warranties contained in the Loan Agreement and all schedules and exhibits thereto are true in all material respects as of the date of this Amendment as though made on the date of this Amendment, except to the extent that such representations and warranties relate expressly to an earlier date.
(D)    Each Borrower is in compliance as of the date of this Amendment with all of the terms and provisions set forth in each Loan Document, and there shall be no fact or condition that could (or could, with the passage of time, the giving of notice, or both) constitute an Event of Default as of the date of this Amendment.
SECTION 7.    GOVERNING LAW.  This Amendment shall be governed by, and construed in accordance with, the law of the State of New York.
SECTION 8.    COUNTERPARTS.  This Amendment may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.  Delivery by facsimile, .pdf or other electronic imaging means of an executed counterpart of a signature page to this Amendment shall be effective as delivery of an original executed counterpart of this Amendment.  Agent may also require that any such documents and signatures delivered by facsimile, .pdf or other electronic imaging means be confirmed by a manually signed original thereof; provided that the failure to request or deliver the same shall not limit the effectiveness of any document or signature delivered by facsimile, .pdf or other electronic imaging means.
[Remainder of page intentionally blank]

IN WITNESS WHEREOF, the parties hereto have caused this First Amendment to Loan and Security Agreement to be duly executed and delivered by their respective proper and duly authorized officers as of the day and year first above written.
BORROWERS:
TRANSENTERIX, INC.
By: /s/ Joseph P. Slattery    
Name: Joseph P. Slattery    
Title: EVP/CFO    
TRANSENTERIX SURGICAL, INC.
By: /s/ Joseph P. Slattery    
Name: Joseph P. Slattery    
Title: EVP/CFO    
TRANSENTERIX INTERNATIONAL, INC.
By: /s/ Joseph P. Slattery    
Name: Joseph P. Slattery    
Title: EVP/CFO    
SAFESTITCH LLC
		
	By:
	TransEnterix, Inc., its sole member

By: /s/ Joseph P. Slattery    
Name: Joseph P. Slattery    
Title: EVP/CFO    

AGENT:
HERCULES CAPITAL, INC.
By: /s/ Jennifer Choe    
Name: Jennifer Choe    
Title: Assistant General Counsel    
LENDERS:
HERCULES CAPITAL, INC.
By: /s/ Jennifer Choe    
Name: Jennifer Choe    
Title: Assistant General Counsel    
HERCULES CAPITAL FUNDING TRUST 2018-1
By: /s/ Jennifer Choe    
Name: Jennifer Choe    
Title: Assistant General Counsel    
HERCULES CAPITAL FUNDING TRUST 2019-1
By: /s/ Jennifer Choe    
Name: Jennifer Choe    
Title: Assistant General Counsel    

SCHEDULE OF EXHIBITS
Exhibit A        Form of AutoLap System Sale Agreement
Exhibit B        Form of UCC-3 Termination Statement
Exhibit F        Form of Compliance Certificate

DMEAST #38378298 v1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]